Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus

• Published in: BMJ open diabetes research & care Vol. 8; no. 1; p. e001206
• Main Authors: Ghanem, Samar Ebrahim, Abdel-Samiee, Mohamed, Torky, Mohamed Hamdy, Gaafar, Ahmed, Mohamed, Somia Mokabel, Salah Eldin, Ghada Mohamed Mohamed, Awad, Samah Mohammed, Diab, Karema A, ELsabaawy, Dalia M, Yehia, Sania Ali, Abdelaziz Elbasyouni, Hany Abdelbary, Elshormilisy, Amr Aly
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group 01.09.2020
• Subjects: Cardiovascular and Metabolic Risk; Case-Control Studies; Diabetes Mellitus, Type 2 - complications; Humans; Interleukin-6; Natriuretic Peptide, Brain; Resistin; Ventricular Dysfunction, Left - etiology; adult diabetes; interleukin-6; echocardiography
• ISSN: 2052-4897; 2052-4897
• DOI: 10.1136/bmjdrc-2020-001206

Epidemiological and genetic studies have recorded the association between proinflammatory cytokines and the development of insulin resistance, diabetes, and cardiovascular disease. The role of interleukin 6 (IL-6), NH2-terminal portion pro-brain natriuretic peptide (NT-proBNP) and resistin in the pathogenesis of heart disease in type 2 diabetes mellitus (T2DM) is still a matter of controversy. The current study aimed to evaluate the role of these biomarkers in the development of left ventricular systolic dysfunction and the ability to use them as non-invasive test in the prediction of left ventricular hypertrophy and systolic dysfunction in T2DM. 150 participants were included in this case-control study. Patients were divided into two subgroups according to echocardiographic findings: group 1a included 46 patients with type 2 diabetes mellitus and echocardiographic evidence of abnormal systolic function; group 1b included 54 patients with type 2 diabetes mellitus and with normal echocardiogenic study; and group 2 included 50 apparently healthy controls. Routine laboratory investigations such as complete blood count, liver and renal function tests, and lipid profile, serum IL-6, NT-proBNP, and resistin were measured in all participants. Conventional echocardiography was done with special concern on the assessment of left ventricular systolic function (ejection fraction). There was a significant increase in the level of resistin, NT-proBNP and IL-6 in group 1a patients compared with group 1b and in healthy controls. Echocardiographic parameters showed a significant increase in left ventricular mass index, left ventricle posterior wall thickness, interventricular septum thickness, and left ventricle mass in group 1a compared with group 1b and the control group. The increased left ventricular mass index was associated with higher levels of IL-6, NT-proBNP and resistin. Proinflammatory cytokines had a clear relation with left ventricular systolic dysfunction and hypertrophy and can be used as early non-invasive markers for detection of left ventricular remodeling and systolic dysfunction in patients with T2DM.